Home LiteratureArticle Details
PMID: 3003587 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Evidence for adenosine receptor-mediated isoprenaline-antagonistic effects of the adenosine analogs PIA and NECA on force of contraction in guinea-pig atrial and ventricular cardiac preparations.

Naunyn-Schmiedeberg's archives of pharmacology ·Vol. 331 ·No. 2-3 ·1985-11-00 ·Pages 131-9

Böhm M, Brückner R, Meyer W, Nose M, Schmitz W, Scholz H, Starbatty J

Abstract

The effects of the adenosine agonists (-)-N6-phenylisopropyladenosine (PIA) and 5'-N-ethylcarboxamideadenosine (NECA) on force of contraction, adenylate cyclase activity and normal as well as slow action potentials were studied in guinea-pig isolated atrial (left auricles) and ventricular preparations (papillary muscles). In auricles PIA and NECA exerted concentration-dependent negative inotropic effects with similar potencies (mean EC50:0.05 mumol l-1 for PIA and 0.03 mumol l-1 for NECA). Similar results were obtained in the presence of isoprenaline. In papillary muscles PIA and NECA alone had no effect on force of contraction but produced negative inotropic effects in the presence of isoprenaline (mean EC50:0.19 mumol l-1 for PIA and 0.10 mumol l-1 for NECA). In both preparations, the negative inotropic effects of PIA and NECA in the presence of isoprenaline were antagonized by the adenosine receptor antagonist 8-phenyltheophylline. In both preparations, PIA and NECA did not affect adenylate cyclase activity, both in the absence and presence of isoprenaline. In auricles the negative inotropic effects of both nucleosides were accompanied by a shortening of the action potential. This effect was also observed in the presence of isoprenaline. In papillary muscles the adenosine analogs did not detectably alter the shape of the normal action potential. Ca2+-dependent slow action potentials elicited in potassium-depolarized preparations also remained unaltered in the presence of PIA or NECA alone. However, the isoprenaline-induced enhancement of the maximal rate of depolarization of slow action potentials was attenuated by PIA or NECA.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH Terms
Action Potentials/drug effects Adenosine/analogs & derivatives,pharmacology Adenosine Deaminase/pharmacology Adenosine-5'-(N-ethylcarboxamide) Adenylyl Cyclase Inhibitors Animals Dipyridamole/pharmacology Female Guinea Pigs Heart Atria/drug effects Heart Ventricles/drug effects In Vitro Techniques Isoproterenol/antagonists & inhibitors Male Myocardial Contraction/drug effects Ouabain/analogs & derivatives,pharmacology Papillary Muscles/drug effects Phenylisopropyladenosine/pharmacology Receptors, Cell Surface/physiology Receptors, Purinergic Theophylline/analogs & derivatives,pharmacology
Chemicals
Adenylyl Cyclase Inhibitors Receptors, Cell Surface Receptors, Purinergic dihydroouabain Phenylisopropyladenosine Adenosine-5'-(N-ethylcarboxamide) Ouabain Dipyridamole Theophylline 8-phenyltheophylline Adenosine Deaminase Adenosine Isoproterenol
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Böhm M
Brückner R
Meyer W
Nose M
Schmitz W
Scholz H
Starbatty J
References (39)
39 references, click to expand
  1. EFFECTS OF CAFFEINE ON MAMMALIAN ATRIAL MUSCLE, AND ITS INTERACTION WITH ADENOSINE AND CALCIUM.
    J Pharmacol Exp Ther. 1965 May;148:202-14 PMID: 14301011
  2. Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect.
    J Pharmacol Exp Ther. 1984 Aug;230(2):483-92 PMID: 6086891
  3. Evidence for an A1-adenosine receptor in the guinea-pig atrium.
    Br J Pharmacol. 1983 Jan;78(1):207-12 PMID: 6297647
  4. Inhibition by purines of the inotropic action of isoprenaline in rat atria.
    Br J Pharmacol. 1983 Sep;80(1):149-53 PMID: 6317127
  5. Modification by islet-activating protein of direct and indirect inhibitory actions of adenosine on rat atrial contraction in relation to cyclic nucleotide metabolism.
    J Cardiovasc Pharmacol. 1983 Jan-Feb;5(1):131-42 PMID: 6186849
  6. Adenosine as inhibitor of myocardial effects of catecholamines.
    Pflugers Arch. 1977 Nov 25;372(1):29-35 PMID: 201920
  7. Inhibition by adenosine of catecholamine-induced increase in rat atrial contractility.
    Am J Physiol. 1980 Sep;239(3):H365-70 PMID: 6254373
  8. Subclasses of external adenosine receptors.
    Proc Natl Acad Sci U S A. 1980 May;77(5):2551-4 PMID: 6248853
  9. Release of adenosine from human hearts during angina induced by rapid atrial pacing.
    J Clin Invest. 1974 May;53(5):1447-57 PMID: 4825235
  10. Adenosine receptor binding: structure-activity analysis generates extremely potent xanthine antagonists.
    Proc Natl Acad Sci U S A. 1983 Apr;80(7):2077-80 PMID: 6300892
  11. Positive inotropic effect of Bay K 8644: cAMP-independence and lack of inhibitory effect of adenosine.
    Naunyn Schmiedebergs Arch Pharmacol. 1985 Jun;329(4):447-50 PMID: 2412140
  12. Two affinity states of Ri adenosine receptors in brain membranes. Analysis of guanine nucleotide and temperature effects on radioligand binding.
    Mol Pharmacol. 1984 Jul;26(1):1-9 PMID: 6087114
  13. Isolated atrial myocytes: adenosine and acetylcholine increase potassium conductance.
    Am J Physiol. 1983 May;244(5):H734-7 PMID: 6846564
  14. Adenosine regulation of canine cardiac adenylate cyclase.
    Biochem Pharmacol. 1981 Feb 15;30(4):369-73 PMID: 7213423
  15. Evidence against adenylate cyclase-coupled adenosine receptors in the guinea pig heart.
    Eur J Pharmacol. 1981 Dec 3;76(2-3):285-8 PMID: 6277647
  16. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells.
    J Neurochem. 1979 Nov;33(5):999-1005 PMID: 228008
  17. Negative inotropic effect of vanadate in ventricular myocardium in the presence of 3-isobutyl-1-methylxanthine or isoprenaline.
    Naunyn Schmiedebergs Arch Pharmacol. 1980;315(2):147-53 PMID: 6163091
  18. Effect of theophylline on myocardial adenylate cyclase activity.
    Experientia. 1978 Apr 15;34(4):504-5 PMID: 639951
  19. Effectiveness of theophylline to increase cyclic AMP levels and force of contraction in electrically paced guinea-pig auricles. Comparison with isoprenaline, calcium and ouabain.
    Naunyn Schmiedebergs Arch Pharmacol. 1977 Dec;301(2):87-97 PMID: 202885
  20. Influence of cyclization and acyl substitution on the inotropic effects of adenine nucleotides.
    Naunyn Schmiedebergs Arch Pharmacol. 1973;278(2):165-78 PMID: 4352122
  21. Cardiac effects of adenosine and adenosine analogs in guinea-pig atrial and ventricular preparations: evidence against a role of cyclic AMP and cyclic GMP.
    J Pharmacol Exp Ther. 1985 Sep;234(3):766-74 PMID: 2993594
  22. Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow.
    Am J Physiol. 1963 Feb;204:317-22 PMID: 13971060
  23. Inhibitory action of adenosine on histamine- and dopamine-stimulated cardiac contractility and adenylate cyclase in guinea pigs.
    Circ Res. 1981 Feb;48(2):259-66 PMID: 6257419
  24. Guanine nucleotide and cation regulation of radioligand binding to Ri adenosine receptors of rat fat cells.
    Naunyn Schmiedebergs Arch Pharmacol. 1984 Jun;326(3):241-7 PMID: 6089005
  25. The potentiation of the action of adenosine on the guinea-pig heart.
    Biochem Pharmacol. 1973 Feb 1;22(3):341-8 PMID: 4687131
  26. An improved assay of cyclic 3',5'-nucleotide phosphodiesterases with QAE-Sephadex columns.
    Naunyn Schmiedebergs Arch Pharmacol. 1980 Mar;311(2):193-8 PMID: 6247661
  27. Effects of vanadate on the c-AMP system of the heart.
    Basic Res Cardiol. 1980 May-Jun;75(3):438-43 PMID: 6255932
  28. Mechanism of adenosine inhibition of catecholamine-induced responses in heart.
    Circ Res. 1983 Feb;52(2):151-60 PMID: 6297829
  29. Adenosine activates a potassium conductance in guinea-pig atrial heart muscle.
    Experientia. 1983 Dec 15;39(12):1347-9 PMID: 6653721
  30. Two distinct adenosine-sensitive sites on adenylate cyclase.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5482-6 PMID: 271970
  31. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart.
    J Physiol. 1929 Nov 25;68(3):213-37 PMID: 16994064
  32. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  33. Adenosine antagonizes the positive inotropic action mediated via beta-, but not alpha-adrenoceptors in the rabbit papillary muscle.
    Eur J Pharmacol. 1980 Aug 8;65(4):445-8 PMID: 6250859
  34. Demonstration of Ri-type adenosine receptors in bovine myocardium by radioligand binding.
    Naunyn Schmiedebergs Arch Pharmacol. 1985 Jan;328(3):310-6 PMID: 2984586
  35. Adenosine receptors mediating cardiac depression.
    Life Sci. 1982 Nov 29;31(22):2425-32 PMID: 7154843
  36. Ionic basis for the antagonism between adenosine and isoproterenol on isolated mammalian ventricular myocytes.
    Circ Res. 1984 Sep;55(3):309-25 PMID: 6088116
  37. Inhibitory adenosine receptors in the heart: characterization by ligand binding studies and effects on beta-adrenergic receptor stimulated adenylate cyclase and membrane protein phosphorylation.
    J Mol Cell Cardiol. 1984 Oct;16(10):931-42 PMID: 6151002
  38. How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?
    J Pharm Pharmacol. 1978 May;30(5):312-3 PMID: 26747
  39. A protein binding assay for adenosine 3':5'-cyclic monophosphate.
    Proc Natl Acad Sci U S A. 1970 Sep;67(1):305-12 PMID: 4318781
Article Info
Journal
Naunyn-Schmiedeberg's archives of pharmacology
Abbr.
Naunyn Schmiedebergs Arch Pharmacol
ISSN
0028-1298
Published
1985-11-00
Pages
131-9
Language
English
Region
Germany
NLM ID
0326264
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com